by Barry101 | Oct 22, 2018 | Press Release
ORLANDO, Fla., Oct. 22, 2018 — Hemispherx Biopharma, Inc. (NYSE American: HEB) announces that Thomas K. Equels, President and Chief Executive Officer, has issued a Letter to Stockholders providing a business update. The full text of the Letter, which has also...
by Barry101 | Oct 10, 2018 | Press Release
New Agreement Expands Existing Preclinical CollaborationsOCALA, Fla., Oct. 10, 2018 — Hemispherx Biopharma, Inc. (NYSE American: HEB) announces the signing of a clinical trial agreement with Roswell Park Comprehensive Cancer Center to evaluate Ampligen in...
by Barry101 | Oct 10, 2018 | Press Release
New Agreement Expands Existing Preclinical CollaborationsOCALA, Fla., Oct. 10, 2018 — Hemispherx Biopharma, Inc. (NYSE American: HEB) announces the signing of a clinical trial agreement with Roswell Park Comprehensive Cancer Center to evaluate Ampligen in...
